T1001	drug 17 27	Nabumetone
T1002	food 78 82	food
T1003	food 84 88	milk
T1004	pharmacokinetics 118 133	bioavailability
T1005	frequency 137 143	single
T1006	mode 144 148	oral
T1009	drug 215 225	nabumetone
T10010	frequency 305 311	single
T10011	mode 312 316	oral
T10012	food 339 343	food
T10013	food 345 349	milk
T10014	population 379 397	healthy volunteers
T10015	drug 418 428	nabumetone
T10017	pharmacokinetics 505 517	plasma level
T10019	dosage 615 622	1000 mg
T10020	drug 623 633	nabumetone
T10021	pharmacokinetics 635 642	maximum
T10022	pharmacokinetics 643 664	plasma concentrations
T10024	value 728 764	9.76, 24.19, and 36.59 micrograms/ml
T10027	drug 961 971	nabumetone
T10028	mealTime 976 991	given with food
T10030	pharmacokinetics 1062 1091	maximum plasma concentrations
T10031	interaction 1123 1132	increased
T10032	parameter 1172 1185	plasma levels
T10033	drug 1201 1211	nabumetone
T10034	pharmacokinetics 1255 1296	area under the plasma concentration curve
T10035	pharmacokinetics 1301 1322	maximum plasma levels
T10036	interaction 1342 1351	increased
T10037	food 1381 1385	milk
T10038	food 1415 1420	water
T10040	drug 1513 1523	nabumetone
T10041	drug 1529 1547	aluminum hydroxide
T10042	food 1590 1595	water
T10043	drug 1618 1628	nabumetone
T10044	drug 1683 1694	paracetamol
T10045	interaction 1696 1724	did not significantly affect
T10046	pharmacokinetics 1729 1742	plasma levels
T10047	pharmacokinetics 1750 1753	AUC
T10048	drugEffect 1801 1810	tolerance
T10049	drug 1814 1824	nabumetone
T10050	drugClass 37 59	anti-inflammatory drug
T10051	drugClass 90 98	antacids
T10052	drugClass 104 114	analgesics
T10053	drugClass 235 257	anti-inflammatory drug
T10054	drugClass 351 359	antacids
T10055	drugClass 365 375	analgesics
T10016	drug 536 567	6-methoxy-2-naphthylacetic acid
T10018	drug 690 721	6-methoxy-2-naphthylacetic acid
T10057	drug 1764 1795	6-methoxy-2-naphthylacetic acid
T10059	drugClass 1641 1651	analgesics
T10060	drug 1659 1679	acetylsalicylic acid
T10061	parameter 1928 1938	hematology
T10062	parameter 1943 1961	clinical chemistry
T10065	dosage 601 604	250
T10066	dosage 606 609	500
T10039	drug 1424 1442	aluminum hydroxide
T10058	mealTime 1859 1866	fasting
T10063	mealTime 1871 1881	nonfasting
T2007	pharmacokinetics 181 191	absorption
T2008	pharmacokinetics 196 211	bioavailability
T20026	pharmacokinetics 870 898	maximum plasma concentration
T20028	food 987 991	food
T20029	pharmacokinetics 997 1031	areas under the plasma level curve
T20023	population 769 788	nonfasting subjects
T20025	pharmacokinetics 816 851	areas under the plasma level curves
T20056	population 1225 1249	male and female subjects
T20058	population 1859 1890	fasting and nonfasting subjects
T20063	interaction 899 906	reached
T20048	pathology 1895 1910	adverse effects
T1	mealTime 769 779	nonfasting
R1	absorption_increase Arg1:T20028 Arg2:T10027	
R2	absorption_increase Arg1:T10037 Arg2:T10033	
